Menu
Not yet recruiting NCT06316089

An Intervention to Improve HIV Pre-exposure Prophylaxis Initiation, Adherence and Linkage to Care for Recently Incarcerated Men Who Inject Drugs.

No phase Interventional Hiv Substance Use Disorders

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: PrEPared for Release.
Who it may be relevant to
Registry conditions: Hiv, Substance Use Disorders. Basic parameters: from 18 years · Male.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Pre-exposure prophylaxis (PrEP) is effective in preventing HIV infection among people who inject drugs (PWID) yet studies suggest that its use is low among this population which is particularly vulnerable to HIV infection. The criminal justice (CJ) system, at the intersection of increased risk of HIV infection and substance use, presents a unique opportunity to engage PWID in HIV prevention care that incudes PrEP. The study will characterize the facilitators and barriers to PrEP initiation, adherence and linkage to care among male PWID that are experiencing incarceration and develop the "PrEPare-for-Release" intervention to promote PrEP initiation, adherence and linkage to care upon release from incarceration into the community.

Interventions

  • Behavioral PrEPared for Release
    A multilevel, behavioral and navigation intervention administered over two sessions to promote PrEP initiation, adherence and linkage to PrEP care in the community for incarcerated men with a history of injection drug use.

Primary outcome measures

  • PrEP initiation [Time frame: Rapid, within 7 days]
Secondary outcome measures (2)
  • Adherence to PrEP [Time frame: At least 30 days]
  • Linkage to PrEP care in the community [Time frame: Within 30 days post-incarceration]

Eligibility criteria

Inclusion criteria

  • At least 18 years of age
  • Incarcerated at the Rhode Island Department of Corrections
  • Identifies as male
  • Reports a history of injection drug use
  • Meets CDC clinical criteria for PrEP use
  • Able to provide written and verbal consent in either English or Spanish

Exclusion criteria

  • Unable to provide written and/or verbal consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06316089 · K23DA054003

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗